The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Share News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.75
ABDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: London stocks tread water with US data to come

Thu, 14th Mar 2024 09:03

(Alliance News) - Stocks in London barely budged after the opening bell on Thursday, after a largely softer session in New York overnight, as eyes turn to a batch of US data and what it can mean for Federal Reserve interest rates.

There will be a customary update on the jobs market, through the initial jobless claims reading at 1230 GMT, as well as an insight into the health of the consumer, with retail sales data. In addition, the latest producer price reading is reported shortly after midday.

The FTSE 100 index rose just 2.97 points to 7,775.14. The FTSE 250 climbed only 4.07 points to 19,567.99, and the AIM All-Share fell 0.17 of a point to 738.65.

The Cboe UK 100 was flat at 778.75, the Cboe UK 250 added 0.1% at 16,945.12, and the Cboe Small Companies was largely unmoved at 14,711.94.

In European equities on Thursday, the CAC 40 in Paris surged 0.8%, while DAX 40 in Frankfurt rose 0.2%.

In New York, the Dow Jones Industrial Average closed up 0.1% on Wednesday. The S&P 500 lost 0.2% and the Nasdaq Composite fell 0.5%.

The pound was quoted at USD1.2806 early Thursday, up from USD1.2798 at the London equities close on Wednesday. The euro stood at USD1.0937, down from USD1.0945. Against the yen, the dollar was trading at JPY147.90, up from JPY147.70.

The US factory gate inflation numbers are expected to show the pace of year-on-year producer price growth picked up to 1.1% on in February, according to FXStreet cited consensus, from 0.9% in January.

Retail sales are expected to have risen 0.8% on month in February, following a 0.8% fall in January from December.

Initial jobless claims are expected to be largely at 218,000 from the prior week's 217,000.

"Overall, we expect the US inflation and activity data to support a delay in the first Fed cut until the middle of the year," analysts at Lloyds Banking Group commented.

"Remarks from ECB speakers today will be very carefully listened to. A first rate cut in April has not been completely ruled out, but indications are that June will be the likelier option. That would provide policymakers with more information about the economy, including Q1 wage data."

ECB executive board members Isabel Schnabel and Luis de Guindos speak at 1100 GMT and 1800 GMT, respectively.

In London, OSB Group tumbled 19% on poorly-received earnings, though it declared a GBP50 million share buyback.

OSB, which stands for OneSavingsBank, said pretax profit in 2023 was 30% lower at GBP374.3 million, from GBP531.5 million in 2022. Total income fell 15% to GBP658.1 million from GBP775.4 million. Hurting its total income, it reported a GBP4.4 million fair value loss on financial instruments, contrasting with a GBP58.9 million gain in 2022. Net interest income alone fell 7.2% to GBP658.6 million in 2023.

The lender in July warned its results would be hurt by customers acting more quickly than expected to refinance their mortgages at favourable rates.

OSB declared a 21.8 pence per share final dividend, unmoved from the year prior. Its total dividend was boosted by 4.9% to 32.0p from 30.5p.

"We have also announced a new GBP50 million share buyback over the next six months and the board will consider additional shareholder returns later in the year," it added.

Further, Chief Financial Officer April Talintyre will not be seeking re-election at the annual general meeting on May 9 and will also retire as executive director that day. Deputy CFO Victoria Hyde will serve as acting CFO until the company finds a new permanent CFO.

Looking to 2024, it does not expect to deliver growth in its underlying net interest margin, which fell to 2.51% in 2023 from 3.03% in 2022. The statutory NIM had fallen to 2.31% last year from 2.78%.

The predicted NIM outcome for 2024 reflects "impact of a higher cost of funds and the full year impact of some lower margin lending in 2023".

Shining on the FTSE 250, however, Trainline added 12%. The rail ticket selling platform said it "outperformed expectations" in its recently-ended financial year.

It said revenue in the year to February 29 rose 21% to GBP397 million from GBP327 million. It had guided for a rise between 15% and 20%. Net ticket sales were 22% higher at GBP5.30 billion, at the top end of its growth outlook range.

Chief Executive Jody Ford said: "Trainline is a home-grown British tech success that has scaled beyond domestic borders to become Europe's most downloaded rail app. We outperformed expectations this year, growing strongly in the UK and across the continent, with International Consumer net ticket sales of more than GBP1 billion."

It was a mixed bag among London-listed large-caps. Diageo rose 1.5% after Kepler raised the brewer to 'buy' from 'hold'. NatWest fell 4.6% as the lender struggled in a negative read across following OSB's report.

Elsewhere, lateral flow test contract development and manufacturing company Abingdon Health painted an optimistic picture. Its shares jumped 27%.

Revenue for the six months to December 31 jumped to GBP2.4 million from GBP1.1 million a year prior. Its pretax loss narrowed to GBP1.2 million from GBP2.4 million.

"The board remains confident of achieving material revenue growth for FY24 compared to FY23, with revenues in H2 2024 also being materially ahead of H1 2024," it said.

In Tokyo on Thursday, the Nikkei 225 closed up 0.3%. The S&P/ASX 200 in Sydney lost 0.2%. The Shanghai Composite closed down 0.2%, while the Hang Seng in Hong Kong ended 0.7% lower.

Gold was quoted at USD2,168.68 an ounce early Thursday, down from USD2,173.55 at the time of the London equities close on Wednesday. Brent oil was quoted at USD84.53 a barrel, climbing from USD83.50.

"Amidst a growing escalation of tensions, Ukraine has carried out drone attacks on Russian oil refineries, triggering a confrontation between the two nations. The largest Rosneft refinery was one of the primary targets in these attacks, resulting in fires and significant damage to the facilities. These acts have affected production and fuel supply in Russia and heightened the already tense relations between both countries," XS.com analyst Antonio Ernesto Di Giacomo commented.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
12 Aug 2021 11:31

AIM WINNERS & LOSERS: Abingdon Health sinks as results disappoint

AIM WINNERS & LOSERS: Abingdon Health sinks as results disappoint

Read more
12 Aug 2021 10:58

Abingdon Health shares plummet on results at bottom end of guidance

Abingdon Health shares plummet on results at bottom end of guidance

Read more
12 Aug 2021 09:15

Abingdon Health FY revenues at bottom end of guidance

(Sharecast News) - Covid-19 test kit manufacturer Abingdon Health warned on Thursday that full-year revenues would be at the bottom end of forecasts.

Read more
23 Jul 2021 10:08

Abingdon Health inks manufacturing agreement for BioSure Covid tests

Abingdon Health inks manufacturing agreement for BioSure Covid tests

Read more
9 Jul 2021 21:41

TRADING UPDATES: JD Sports vows diversity, Sainsbury faces mini-revolt

TRADING UPDATES: JD Sports vows diversity, Sainsbury faces mini-revolt

Read more
5 Jul 2021 18:49

TRADING UPDATES: AVI wants Third Point change; ADVFN plans dividend

TRADING UPDATES: AVI wants Third Point change; ADVFN plans dividend

Read more
27 Apr 2021 10:32

Abingdon Health expects to report annual results below market forecast

Abingdon Health expects to report annual results below market forecast

Read more
27 Apr 2021 10:30

AIM WINNERS & LOSERS: Abingdon Health warns results to miss forecasts

AIM WINNERS & LOSERS: Abingdon Health warns results to miss forecasts

Read more
27 Apr 2021 09:54

Abingdon Health looks set to report FY underlying loss

(Sharecast News) - Abingdon Health warned on Tuesday that it looked set to post a full-year underlying loss despite stating it had continued to make progress on commercialising its AbC-19TM rapid test in the UK private sector and internationally.

Read more
10 Mar 2021 14:05

IN BRIEF: Abingdon Health signs distribution agreement with BioSure UK

IN BRIEF: Abingdon Health signs distribution agreement with BioSure UK

Read more
10 Mar 2021 09:27

Abingdon Health inks sales and distribution agreement with BioSure UK

(Sharecast News) - Rapid tests developer Abingdon Health has signed a non-exclusive sales and distribution agreement in the UK and Europe for its AbC-19 rapid neutralising antibody test with BioSure UK.

Read more
9 Mar 2021 17:07

TRADING UPDATES: Science Group swings to profit, eEnergy revenue grows

TRADING UPDATES: Science Group swings to profit, eEnergy revenue grows

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
24 Feb 2021 12:12

Omega Diagnostics And Abingdon Note Encouraging Covid-19 Test Data

Omega Diagnostics And Abingdon Note Encouraging Covid-19 Test Data

Read more
16 Feb 2021 11:38

Abingdon Health, Omega Diagnostics Note "Highly Accurate" Covid Test

Abingdon Health, Omega Diagnostics Note "Highly Accurate" Covid Test

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.